Výsledky vyhledávání - "монотерапия"

Akademický článek

Adjusting the role of hydroxychloroquine with or without azithromycin in patients with COVID-19

Autor: V. A. Otdelenov, Yu. Yu. Kiselev, K. B. Mirzaev, A. V. Matveev, D. A. Sychev

Publikováno v: Качественная клиническая практика, Vol 0, Iss 4S, Pp 53-59 (2020)

Taking recent publications into account, one should consider avoiding routine use of hydroxychloroquine, especially if combined with azithromycin, for COVID-19. Such treatment may be associated with the increased risk for hospital mortality and QT pr

Externí odkaz: https://doaj.org/article/277ef40b470e486eb66c951af4df2b9b

Zobrazit plný text záznamu

Akademický článek

SGLT2 inhibitors: control of glycemia and nephroprotection properties

Autor: A. A. Volodin, M. L. Maximov, V. G. Slobodyan, R. N. Alyautdin

Publikováno v: Безопасность и риск фармакотерапии, Vol 5, Iss 1, Pp 11-26 (2018)

Recently were appeared a fundamentally new insulin-independent approach to the treatment of type 2 diabetes - reduce blood glucose levels by inhibiting proteins co-transporters SGLT2 (sodium glucose transporter) in the proximal tubules of the kidneys

Externí odkaz: https://doaj.org/article/a58213ca33004a478099763e5ba2cddd

Zobrazit plný text záznamu

Akademický článek

Phycoemotional state of the patients with severe acne associated with isotretinoin therapy

Autor: M. L. Aripova, S. A. Khardikova

Publikováno v: Vestnik Dermatologii i Venerologii, Vol 0, Iss 5, Pp 122-127 (2017)

Progression of phycoemotional state of 22 patients with severe acne was assessed based on changes in rates of CADI, APSEA, DSQL. Monotherapy with isotretinoin (Acnecutan) is effective in treating severe acne resistant to therapy providing stable remi

Externí odkaz: https://doaj.org/article/c39c0b3ec0ec4844a87d82eabbd259b9

Zobrazit plný text záznamu

Значение Комбинированной Медикаментозной Терапии В Лечении Артериальной Гипертензии

Autor: Editor Academic Journals &Amp; Conferences

Только от 40% до 50% пациентов с АГ достигают артериального давления

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4b288306d4d2163f86b28b00b1b1df8d

Zobrazit plný text záznamu

Rasagiline: a second-generation MAO-B inhibitor for the treatment of Parkinson’s disease

Autor: M.V. Polivoda

Publikováno v: INTERNATIONAL NEUROLOGICAL JOURNAL; Том 16, № 7 (2020); 70-77
МЕЖДУНАРОДНЫЙ НЕВРОЛОГИЧЕСКИЙ ЖУРНАЛ; Том 16, № 7 (2020); 70-77
МІЖНАРОДНИЙ НЕВРОЛОГІЧНИЙ ЖУРНАЛ; Том 16, № 7 (2020); 70-77

Parkinson’s disease is the second most common neurodegenerative disorder, affecting 1 to 2 % of people older than 60 years. Rasagiline is a potent and irreversible monoamine oxidase type B (MAO-B) inhibitor which has been approved for the treatment

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a02dd4e502cd3b59f4c2a7c4db793dd
https://doi.org/10.22141/2224-0713.16.7.2020.218700

Zobrazit plný text záznamu

Akademický článek

EFFICACY OF DIFFERENT TACTICS FOR INITIAL ANTIHYPERTENSIVE THERAPY

Autor: O. A. Pleyko, A. O. Konrady

Publikováno v: Рациональная фармакотерапия в кардиологии, Vol 3, Iss 1, Pp 21-27 (2015)

Aim. To evaluate different tactics of initial antihypertensive therapy.Material and Methods. 120 patients with mild-to-moderate arterial hypertension were included and randomized into three groups: “A”, “B”, and “C”. 5 drugs from the main

Externí odkaz: https://doaj.org/article/7707f2ff077a46d1b7559900d2a7889c

Zobrazit plný text záznamu